Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway

Pancreatic ductal adenocarcinoma (PDAC) has one of the highest mortality rates and requires the development of highly efficacious medications that can improve the efficiency of existing treatment methods. In particular, in PDAC, resistance to conventional chemotherapy reduces the effectiveness of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Limbu, Khem Raj, Chhetri, Rashmi Bhandari, Oh, Yoon Sin, Baek, Dong Jae, Park, Eun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739667/
https://www.ncbi.nlm.nih.gov/pubmed/36500220
http://dx.doi.org/10.3390/molecules27238127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739667/
https://www.ncbi.nlm.nih.gov/pubmed/36500220
http://dx.doi.org/10.3390/molecules27238127

Ejemplares similares